366 related articles for article (PubMed ID: 10662603)
1. Teratogenicity, tissue distribution, and metabolism of the retro-retinoids, 14-hydroxy-4,14-retro-retinol and anhydroretinol, in the C57BL/6J mouse.
Mao GE; Collins MD; Derguini F
Toxicol Appl Pharmacol; 2000 Feb; 163(1):38-49. PubMed ID: 10662603
[TBL] [Abstract][Full Text] [Related]
2. Extraction of human epidermis treated with retinol yields retro-retinoids in addition to free retinol and retinyl esters.
Duell EA; Derguini F; Kang S; Elder JT; Voorhees JJ
J Invest Dermatol; 1996 Aug; 107(2):178-82. PubMed ID: 8757759
[TBL] [Abstract][Full Text] [Related]
3. Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse.
Eckhoff C; Löfberg B; Chahoud I; Bochert G; Nau H
Toxicol Lett; 1989 Aug; 48(2):171-84. PubMed ID: 2772923
[TBL] [Abstract][Full Text] [Related]
4. Retro-retinoids in regulated cell growth and death.
O'Connell MJ; Chua R; Hoyos B; Buck J; Chen Y; Derguini F; Hämmerling U
J Exp Med; 1996 Aug; 184(2):549-55. PubMed ID: 8760808
[TBL] [Abstract][Full Text] [Related]
5. Identification of 14-hydroxy-retro-retinol and 4-hydroxy-retinol as endogenous retinoids in rats throughout neonatal development.
Rühl R; Hamscher G; Garcia AL; Nau H; Schweigert FJ
Life Sci; 2005 Feb; 76(14):1613-22. PubMed ID: 15680170
[TBL] [Abstract][Full Text] [Related]
6. Prevention of vitamin A teratogenesis by phytol or phytanic acid results from reduced metabolism of retinol to the teratogenic metabolite, all-trans-retinoic acid.
Arnhold T; Elmazar MM; Nau H
Toxicol Sci; 2002 Apr; 66(2):274-82. PubMed ID: 11896294
[TBL] [Abstract][Full Text] [Related]
7. Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells.
Eppinger TM; Buck J; Hämmerling U
J Exp Med; 1993 Dec; 178(6):1995-2005. PubMed ID: 8245778
[TBL] [Abstract][Full Text] [Related]
8. Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption.
Arnhold T; Tzimas G; Wittfoht W; Plonait S; Nau H
Life Sci; 1996; 59(12):PL169-77. PubMed ID: 8809215
[TBL] [Abstract][Full Text] [Related]
9. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of topical retinaldehyde and retinol by mouse skin in vivo: predominant formation of retinyl esters and identification of 14-hydroxy-4, 14-retro-retinol.
Sass JO; Didierjean L; Carraux P; Plum C; Nau H; Saurat JH
Exp Dermatol; 1996 Oct; 5(5):267-71. PubMed ID: 8981025
[TBL] [Abstract][Full Text] [Related]
11. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice.
Kochhar DM; Penner JD; Satre MA
Toxicol Appl Pharmacol; 1988 Dec; 96(3):429-41. PubMed ID: 3206525
[TBL] [Abstract][Full Text] [Related]
12. 13,14-Dihydroxy-retinol, a new bioactive retinol metabolite.
Derguini F; Nakanishi K; Hämmerling U; Chua R; Eppinger T; Levi E; Buck J
J Biol Chem; 1995 Aug; 270(32):18875-80. PubMed ID: 7642543
[TBL] [Abstract][Full Text] [Related]
13. Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: risk of vitamin A exposure in humans.
Tzimas G; Collins MD; Bürgin H; Hummler H; Nau H
J Nutr; 1996 Sep; 126(9):2159-71. PubMed ID: 8814204
[TBL] [Abstract][Full Text] [Related]
14. 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse.
Collins MD; Eckhoff C; Chahoud I; Bochert G; Nau H
Arch Toxicol; 1992; 66(9):652-9. PubMed ID: 1482289
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling activity of synthetic (14R)-, (14S)-, and (14RS)-14-hydroxy-4,14-retro-retinol.
Derguini F; Nakanishi K; Hämmerling U; Buck J
Biochemistry; 1994 Jan; 33(3):623-8. PubMed ID: 8292589
[TBL] [Abstract][Full Text] [Related]
16. Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.
Buck J; Grün F; Derguini F; Chen Y; Kimura S; Noy N; Hämmerling U
J Exp Med; 1993 Aug; 178(2):675-80. PubMed ID: 8340762
[TBL] [Abstract][Full Text] [Related]
17. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
18. Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: important role of retinal dehydrogenase type 2 in synthesis of all-trans-retinoic acid.
Ulven SM; Gundersen TE; Weedon MS; Landaas VO; Sakhi AK; Fromm SH; Geronimo BA; Moskaug JO; Blomhoff R
Dev Biol; 2000 Apr; 220(2):379-91. PubMed ID: 10753524
[TBL] [Abstract][Full Text] [Related]
19. Distribution of endogenous retinoids, retinoid binding proteins (RBP, CRABPI) and nuclear retinoid X receptor beta (RXRbeta) in the porcine embryo.
Schweigert FJ; Siegling C; Tzimas G; Seeger J; Nau H
Reprod Nutr Dev; 2002; 42(4):285-94. PubMed ID: 12510870
[TBL] [Abstract][Full Text] [Related]
20. Teratogenic profile of retinylidene methyl nitrone and retinol in Swiss-Webster mice.
Willhite CC; Balogh-Nair V
Teratog Carcinog Mutagen; 1985; 5(5):355-63. PubMed ID: 2867618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
